Reliq Health Technologies Inc V.RHT.H

nothing seems to move the needle! what can RHT do

[Humanist]

to move the stock. it appears investors are losing faith.. earnings never delivered as promised, contracts  don't move the needle anymore.. no nasdaq listing, no major analysts following us or fund manager intersted.. i am sure I am forgetting something ..

so what does rht need to move upwards..  of course profit isthe answer but how do we get there... ! 

ive been in here for over 5 years and was hopefull for the longest time.. now its a question mark what to do..

thoughts are welcome

p.s. weve been trading between 40 & 50 cents since 2019 allowing for some spikes and falling back so..

[Lifeboat1]

As an investor you can't really look back you have to look forward and ask yourself is there a better investment out there that has the potential for a bigger return than Reliq in the next year with a minimal downside risk (40c - 50c range IMO if they only grow marginally 20-50% a year).  I don't consider anything before July 2021 (end of Covid as a major business obstacle for

[Lifeboat1]

The stock is undervalued IMO and will continue to lag until financials support the expected growth.  Once they do the stock will likely not be undervalued and will increase significantly in a short period of time.  It is a waiting game until that happens.  It may be 1 quarter or it may be a year but I don't see it being longer than that.  As a long the low price relative to

[lscfa]

Reliq needs to be more transparent.      Like many co.s it did not provide Q4 no.s, only full year no.s, leaving investors guessing about Q4. If you subtract Q1,Q2,Q3 from FY you get nonsense no.s. (see table) which are incorrect because the co. reported revised revenues in its 8 qtr summary in the MD&A.     Below is my guesstimate of the last 6 qtrs using revised no

[lscfa]

p.s. Reliq needs to do a better job reporting unaudited quarterly no.s too. If they are going to be revised by the annual audit nobody will believe them.

[qwerty22]

Here's my problem, things still don't add up. Assume your revised numbers are right. They add $200,000 to $400,000 extra SaaS revenue each quarter with no evidence of any accelerating trend.. Take $300,000, at $65 per patient that would mean ~4500 new patients per quarter or ~1500 per month (I'm ignoring dropout for now). The last 3 new reported contracts alone said 55,000 patients

[lscfa]

Note the large jump in SAAS costs in the December qtr. I assume this is the addition of care mgmt staff either in house or via Cognizant to get patient adherence up. March qtr should be telling. If Lisa wants the damn stock price to rise then reveal some prelim revenues on the April 12 webinar.

[Mitch43]

Did you factor in the 2million something RHT had topay to settle alawsuit?!

[Lifeboat1]

It was $600k out of pocket after insurance and their payment from suing former employees.  It was accrued over a year ago so is not in current financials

[Mitch43]

Thanks for letting me know... Time really fly fast...